Jack coordinates the firm’s cannabis business practice in Washington State, by assisting clients in navigating the complex licensing and regulatory system created by Initiative 502. He has counseled numerous companies through compliance and transactional issues including M&A, license transfers, real estate financing, distribution agreements, and goods and services agreements. In addition to his cannabis practice, Jack also advises clients on a wide range of matters at the intersection of business and immigration, including specialty investment and employment visa issues and administrative advocacy.
Washington’s House and Senate have both approved the “Washington Psilocybin Services Act” (SB 5263) and the bill awaits Governor Jay Inslee’s signature. Psilocybin is a schedule I drug under the federal Controlled Substances Act and is the psychoactive or “hallucinogenic” component of magic mushrooms. Washington appears set to follow in the footsteps of Oregon and
On January 6, lawmakers filed a Washington psilocybin legalization bill, SB 5660, the Washington Psilocybin Services Wellness and Opportunity Act. Two attorneys in our law firm’s psychedelics practice, Mason Marks and John Rapp, helped craft this vanguard bill (Mason’s write-up is here). In the event legalization of psilocybin occurs in Washington, this post covers what
In a continuing trend across the country whereby cities are taking steps to decriminalize the possession of certain amounts of all kinds of psychedelics, Seattle joined the herd this week by voting to formalize the non-prosecution of the possession of certain entheogens, commonly known as psychedelics. We were especially gratified to see the results of
